-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JpMecgH/JbAIpM+A7Xoc5YfBMTZ1/TuVdT2GNr3n3ceDsRG/A+MWwM4ePp76WPhJ klFCmX3vh1GU4Cy4qVuzvg== 0001209191-05-037072.txt : 20050714 0001209191-05-037072.hdr.sgml : 20050714 20050714133725 ACCESSION NUMBER: 0001209191-05-037072 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050712 FILED AS OF DATE: 20050714 DATE AS OF CHANGE: 20050714 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CORIXA CORP CENTRAL INDEX KEY: 0001042561 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911654387 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1900 9TH AVENUE STREET 2: SUITE 1100 CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: 2063663700 MAIL ADDRESS: STREET 1: 1900 9TH AVENUE STREET 2: SUITE 1100 CITY: SEATTLE STATE: WA ZIP: 98101 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FANNING DAVID CENTRAL INDEX KEY: 0001229763 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22891 FILM NUMBER: 05954079 MAIL ADDRESS: STREET 1: 1301 FIRST AVENUE STREET 2: #1505 CITY: SEATTLE STATE: WA ZIP: 98101 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2005-07-12 1 0001042561 CORIXA CORP CRXA 0001229763 FANNING DAVID 1900 9TH AVENUE SUITE 200 SEATTLE WA 98101 0 1 0 0 Sr. Vice President, COO Common Stock 2005-07-12 4 M 0 150000 3.95 A 181026 D Common Stock 2005-07-12 4 D 0 150000 4.40 D 31026 D Common Stock 2005-07-12 4 D 0 31026 4.40 D 0 D Incentive Stock Option 3.95 2005-07-12 4 M 0 150000 0.00 D 2005-07-12 2014-12-15 Common Stock 150000 0 D Incentive Stock Option 6.04 2005-07-12 4 D 0 21094 0.00 D 2005-07-12 2013-12-31 Common Stock 21094 0 D Incentive Stock Option 6.41 2005-07-12 4 D 0 4062 0.00 D 2005-07-12 2013-01-03 Common Stock 4062 0 D Incentive Stock Option 10.40 2005-07-12 4 D 0 46793 0.00 D 2005-07-12 2011-10-01 Common Stock 46793 0 D Non-Qualified Stock Option 5.70 2005-07-12 4 D 0 75000 0.00 D 2005-07-12 2014-12-15 Common Stock 75000 0 D Non-Qualified Stock Option 6.04 2005-07-12 4 D 0 19406 0.00 D 2005-07-12 2013-12-31 Common Stock 19406 0 D Non-Qualified Stock Option 6.41 2005-07-12 4 D 0 10938 0.00 D 2005-07-12 2013-01-03 Common Stock 10938 0 D Non-Qualified Stock Option 6.70 2005-07-12 4 D 0 50000 0.00 D 2005-07-12 2012-10-04 Common Stock 50000 0 D Non-Qualified Stock Option 10.40 2005-07-12 4 D 0 253207 0.00 D 2005-07-12 2011-10-01 Common Stock 253207 0 D Pursuant to the Merger Agreement with GSK, these options were cancelled at the time the merger. Net cash consideration was received. Pursuant to the Merger Agreement with GSK, the underlying option was cancelled cancelled at the time of the Merger. No cash consideration was received for the cancellation. Greg Cox (Attorney in fact)for: David Fanning 2005-07-14 -----END PRIVACY-ENHANCED MESSAGE-----